- Service Name
ASCEND
- Industry
Pharmaceutical, Research & Development, Biotechnology, Artificial Intelligence
- Main Value Proposition
ASCEND enhances the research process by providing scientists with advanced tools to decode complex biological data, leading to improved experimental outcomes and productivity.
- Description
ASCEND is a generative AI platform designed specifically for pharmaceutical research and development, focusing on unraveling disease biology. It acts as a co-pilot for scientists, enhancing decision-making and productivity in research.
- Key Features
Robust structured data foundation for scientific diversity and explainability; Specialized AI assistants tailored for pharma workflows; Enterprise-ready integrations for seamless data management; Proprietary multimodal biological LLMs for understanding experiments
- Use Cases
ASCEND is most valuable in scenarios such as drug discovery, experimental design, and data analysis in pharmaceutical research and development.
- Competitive advantages
Access to the most comprehensive dataset of closed-access papers; Deep understanding of pharma workflows across multiple dimensions; Dedicated service team of scientists and engineers for support and integration
- Strengths
ASCEND's strengths lie in its robust data foundation, specialized AI assistants, and enterprise-ready integrations that collectively enhance the research capabilities of pharmaceutical companies.
- Positioning
ASCEND positions itself as a cutting-edge AI solution that simplifies and accelerates the complexities of biomedical research for pharmaceutical companies.
- Audience
The primary target users are pharmaceutical researchers, scientists involved in drug development, and R&D teams looking to enhance their research efficiency.
- CTA
Request a Demo
- Tags
Generative AI
Pharmaceutical Research
Biomedical Discovery
Data Integration
- Tagline
The Disease Biology Generative AI Platform for Pharma R&D
- Tone of Voice
Innovative, authoritative, supportive
- Differentiation
ASCEND stands out in the market due to its proprietary ontology knowledge base and multimodal AI capabilities, which allow it to integrate and analyze vast amounts of scientific data from diverse sources.
- Brand Positioning
BenchSci, the company behind ASCEND, is positioned as a leader in AI solutions for preclinical R&D, emphasizing innovation and advanced technology in biomedical research.
- Founded
2015-01-01
- Founders
David Qixiang Chen
Elvis Wianda
Liran Belenzon
Tom Leung